/ Register

Studies from ShiroIshii

  1. ShiroIshii

    Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use

    ShiroIshii, Jan 31, 2025, Addiction
    Expanding naloxone access in 44 US states did not increase adolescent heroin or injection drug use,
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 31, 2025
  2. ShiroIshii

    Health economic design for cost, cost-effectiveness and analyses in the HEALing Communities Study

    ShiroIshii, Jan 30, 2025, Addiction
    The study concludes that a comprehensive health economic approach is crucial for assessment.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 30, 2025
  3. ShiroIshii

    Knowledge, preparedness, and compassion fatigue among LEOs who respond to opioid overdose

    ShiroIshii, Jan 30, 2025, Opiate Addiction
    The study links officers' overdose knowledge and preparedness to their risk of compassion fatigue.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 30, 2025
  4. ShiroIshii

    Drug Enforcement Administration's 2024 National Drug Threat Assessment

    ShiroIshii, Jan 23, 2025, Law
    Provides a comprehensive analysis of the most pressing illicit drug threats facing USA.
    0/5, 0 ratings
    Downloads:
    2
    Updated:
    Jan 23, 2025
  5. ShiroIshii

    EU Drug Market Analysis 2024

    ShiroIshii, Jan 23, 2025, Drug Use
    Europe's illicit drug market is valued at over €31 billion, with high availability across all drugs.
    0/5, 0 ratings
    Downloads:
    1
    Updated:
    Jan 23, 2025
  6. ShiroIshii

    National Survey Results on Drug Use, 1975–2024: Overview and key findings

    ShiroIshii, Jan 23, 2025, Drug Use
    Drug use continues to decline giving credit to prevention efforts and evolving societal norms.
    0/5, 0 ratings
    Downloads:
    1
    Updated:
    Jan 23, 2025
  7. ShiroIshii

    Australian Drug Trends 2024

    ShiroIshii, Jan 23, 2025, Drug Use
    underscores the need for optimal approaches to reduce harm and build resilient communities.
    0/5, 0 ratings
    Downloads:
    3
    Updated:
    Jan 23, 2025
  8. ShiroIshii

    European Drug Report 2024

    ShiroIshii, Jan 23, 2025, Drug Use
    emphasizes the need for optimal strategies to address Europe’s evolving drug issues.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 23, 2025
  9. ShiroIshii

    World Drug Report 2024

    ShiroIshii, Jan 23, 2025, Drug Use
    The report calls for optimal cooperation and policies for a sustainable approach to combat drug use.
    0/5, 0 ratings
    Downloads:
    2
    Updated:
    Jan 23, 2025
  10. ShiroIshii

    Afghanistan Drug Insights Volume 2

    ShiroIshii, Jan 23, 2025, Opium & Poppy
    This study underscores the urgency for evidence-based approaches to tackle Afghanistan’s drug trade.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 23, 2025
  11. ShiroIshii

    Afghanistan Drug Insights Volume 1

    ShiroIshii, Jan 22, 2025, Opiates & Opioids Chemistry
    The latest data and in-depth analysis on aspects of the evolving drug situation in Afghanistan.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 22, 2025
  12. ShiroIshii

    Multi-session electrical neuromodulation effects on cocaine use disorder

    ShiroIshii, Jan 19, 2025, Cocaine Addiction
    A randomized, sham-controlled tDCS study in relapse, cravings and cognitive functions
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 19, 2025
  13. ShiroIshii

    Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework

    ShiroIshii, Jan 19, 2025, Hallucinogens in general
    Psychedelic-assisted therapy is becoming mainstream, but knowledgeable professionals still required.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 19, 2025
  14. ShiroIshii

    The cost of opioid use disorder and the value of aversion

    ShiroIshii, Jan 18, 2025, Opiate Addiction
    This study provided updated estimates of the economic burden associated with OUD.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 18, 2025
  15. ShiroIshii

    The Opioid-overdose Reduction Continuum of Care Approach (ORCCA)

    ShiroIshii, Jan 18, 2025, Opiate Addiction
    Evidence-based practices in the HEALing Communities Study.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 18, 2025
  16. ShiroIshii

    Tramadol non-medical use in Four European countries: A comparative analysis

    ShiroIshii, Jan 18, 2025, Tramadol
    Tramadol misuse and abuse are low compared to other opioids in four European countries.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 18, 2025
  17. ShiroIshii

    Introducing NIDA’s New National Drug Early Warning System

    ShiroIshii, Jan 18, 2025, Drug Use
    The system relies on trends found by the scientific network funded by the NIH and other agencies.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 18, 2025
  18. ShiroIshii

    Online surveillance of novel psychoactive substances (NPS)

    ShiroIshii, Jan 18, 2025, Drug Culture
    Monitoring Reddit discussions as a predictor of increased NPS-related exposures.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 18, 2025
  19. ShiroIshii

    Myanmar Opium Survey 2024

    ShiroIshii, Jan 18, 2025, Opium & Poppy
    Cultivation, production, and implications of opium in Myanmar in 2024
    5/5, 1 rating
    Downloads:
    2
    Updated:
    Jan 18, 2025
  20. ShiroIshii

    Opium and agrarian change in the ceasefire landscapes of south-western Shan State, Myanmar

    ShiroIshii, Jan 18, 2025, Opium & Poppy
    Opium cultivation has given poor farmers a way to mitigate their chronic livelihood insecurities.
    0/5, 0 ratings
    Downloads:
    0
    Updated:
    Jan 18, 2025
Page 1 of 2